These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31509441)

  • 1. Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation.
    Guo F; Hu B; Chen L; Li J
    Br J Radiol; 2019 Nov; 92(1103):20190183. PubMed ID: 31509441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
    Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
    Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour.
    Hoeffel C; Pousset M; Timsit MO; Elie C; Méjean A; Merran S; Tranquart F; Khairoune A; Joly D; Richard S; Hélénon O; Correas JM
    Eur Radiol; 2010 Aug; 20(8):1812-21. PubMed ID: 20204642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasound for assessment of therapeutic response after percutaneous radiofrequency ablation of small renal tumors.
    Garbajs M; Popovic P
    J BUON; 2016; 21(3):685-90. PubMed ID: 27569091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
    Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
    Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients.
    Zhao X; Wang W; Zhang S; Liu J; Zhang F; Ji C; Li X; Gan W; Zhang G; Guo H
    Abdom Imaging; 2012 Oct; 37(5):885-91. PubMed ID: 22131041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Contrast-Enhanced Ultrasound Scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases.
    Zeccolini G; Del Biondo D; Cicero C; Casarin A; Guarise A; Celia A
    Urologia; 2014; 81 Suppl 23():S1-8. PubMed ID: 24665032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced Ultrasonography for Surveillance of Radiofrequency-ablated Renal Tumors: A Prospective, Radiologist-blinded Pilot Study.
    Allard CB; Coret A; Dason S; Tajzler C; Shayegan B; Matsumoto ED; Kapoor A
    Urology; 2015 Dec; 86(6):1174-8. PubMed ID: 26123518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring laparoscopic radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: an open-label, randomized, comparative pilot trial.
    Chen Y; Huang J; Xia L; Dong B; Chen W; Xue W; Liu D; Huang Y
    J Endourol; 2013 Jun; 27(6):697-704. PubMed ID: 23442174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study.
    Bartoș A; Bartos D; Spârchez Z; Iancu I; Ciobanu L; Iancu C; Breazu C
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):457-462. PubMed ID: 31826072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
    Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
    J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
    Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
    Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation of renal tumors: four-year follow-up results in 47 patients.
    Kim SD; Yoon SG; Sung GT
    Korean J Radiol; 2012; 13(5):625-33. PubMed ID: 22977331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
    Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
    Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
    Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
    Lee Y; Yoon JH; Han S; Joo I; Lee JM
    Cancer Imaging; 2024 Jan; 24(1):4. PubMed ID: 38172949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.
    Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H
    J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.